Prenatal antidepressant use and risk of adverse neonatal outcomes
The SURMOUNT-1 trial, which studied tirzepatide in people living with obesity without diabetes, found that participants experienced: A 33.9% reduction in fat mass A 10.9% reduction in lean mass While this might seem concerning at first glance, its essential to understand that some lean mass loss during significant weight loss is normal and expected
Always consult with your doctor or other qualified healthcare professional about any questions you may have regarding a medical condition or treatment options
J Clin Oncol 40(suppl 16):ABSTR e16225, 2022
Inadequate protein intake below 0.8 grams per kilogram of body weight per day accelerates muscle breakdown, which further reduces metabolic rate and deepens fatigue
For patients dealing with the systemic inflammation of chronic illness, lowering homocysteine through B12 supplementation is a critical step in reducing the overall burden of oxidative stress on the body